Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Pasic

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
JCO Oncology Practice|June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic TransplantationNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
JCO Oncology Practice|June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic TransplantationNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 5, 2023
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHDIgor Novitzky-Basso, Christopher Patriquin, Swe Mar Linn, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Pageof 10